Skip to main content
  • david-wohl-discussing-mandate-removal-ABC 11

    Wohl Expresses Concern For Resuming Normal Activities Too Soon.

    David Wohl, MD David Wohl, MD, professor of medicine in the division of infectious diseases, expressed concern for North Carolinians resuming normal activities to soon. In a News & Observer article, Wohl said that he worries the current decline in COVID-19 cases is the back slope of the post-holiday surge. He also added the slowing of the decline may reflect the arrival of vi … Read more

  • wohl-moll-featured-photo

    Should You Be Concerned About Blood Clots, Bleeding and the AZ-Vaccine?

    David Wohl, MD, and Stephan Moll, MD While millions of people in dozens of countries have received the AstraZeneca Covid vaccine with few reports of ill effects, and its prior testing in tens of thousands of people found it to be safe, the vaccine is being investigated. A New York Times article explains the decision to pause the vaccine in European countries, with concerns about … Read more

  • david-wohl-discussing-mandate-removal-ABC 11

    Wohl Discusses Moderna Testing in Young Children, Outreach For Group 4 and Fears Over Side Effects

    David Wohl, MD David Wohl, MD, talked with the New York Times about a study that will test the Moderna vaccine in children under 12, including babies as young as six months old. He said the study appears well designed and likely to be efficient, but he questioned why children were to be followed for only one year, when adults in Moderna’s study are followed for two years. He also … Read more

  • joe-eron

    Getting answers: I’m a teacher. How can I best keep my unvaccinated students safe?

    Joe Eron, MD Joe Eron, MD, professor of medicine and chief of the division of infectious diseases, was consulted for a CBS17.com news story about when COVID-19 vaccines might be available for school-aged children and precautions that should continue. Read the story here.        

  • wohl-weber

    UNC Health Marks One Year Since NC’s First COVID-19 Case

    David Wohl, MD, and David Weber, MD David Wohl, MD, and David Weber, MD, are featured in a UNC Health video that marks one year since North Carolina’s first COVID-19 case.  Published on WRAL.com, the video also includes Wesley Burks, MD, Alexa Mieses-Malchuk, MD, MPH, Samantha Meltzer-Brody, MD, and Melissa Miller, PhD. Watch the video here.

  • emily-ciccone

    Single Vaccine Dose May Offer Protection to Those Who Have Had COVID-19

    Emily Ciccone, MD, MHS UNC-Chapel Hill research, led by Emily Ciccone, MD, MHS, instructor and fellow in the division of infectious diseases, and Allison Aiello, PhD, professor of epidemiology and Carolina Population Center Fellow, shows that individuals previously infected with SARS-CoV-2 develop a significant antibody response to the first dose of mRNA-based COVID-19 vaccines. … Read more

  • David Wohl, MD-Roundup-Covid-News-February-2022

    Wohl Talks With Media About Second Doses of Vaccine, Eased NC Restrictions and J&J Vaccine Approval

    David Wohl, MD After winter weather delayed the delivery of 6 million vaccine doses nationwide, David Wohl, MD, professor of medicine in the division of infectious diseases, addressed concerns about the supply of second vaccine doses in a WRAL.com interview.  He explained how health systems like UNC Health planned ahead and have second doses in reserve. Find the interview here. I … Read more

  • emily-sickbert-cbs-17-wearing-a-mask

    UNC Health Media Briefing: Sickbert-Bennett Discusses Double-Masking and the Importance of Mask Fit

    Emily Sickbert-Bennett, PhD, MS Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD, spoke with media about research and guidance on wearing masks, double-masking, and the importance of mask material and fit.  Find a link to the briefing in the UNC Health and UNC School of Medicine Newsroom. Sickbert-Bennett and Clapp were also featured in a Yahoo News article explaining these gu … Read more

  • Adaora A. Adimora, MD, MPH

    US Failing to Reach Those Most in Need of HIV Prevention, Treatment Services in South and Rural Areas

    Adaora A. Adimora, MD, MPH Adaora Adimora, MD, MPH, professor of medicine in the division of infectious diseases, co-authored a six-paper series in The Lancet focused on racial, sexual, and gender minorities continuing to be affected by HIV at significantly higher rates than white people, a disparity also reflected in the COVID-19 pandemic.  Learn more from the UNC Health and UNC … Read more

  • emily-sickbert-cbs-17-wearing-a-mask

    Sickbert-Bennett Discusses Mask Fit and Efficiency

    Emily Sickbert-Bennett, PhD, MS Emily Sickbert-Bennett, PhD, MS, associate professor of infectious diseases, in the division of infectious diseases, and director of the UNC Medical Center Infection Prevention, continues to share perspective and study learnings about mask filtration efficiencies. She contributed to the following news reports this month. How to avoid buying counter … Read more

  • CindyGay-newsworthy-nov-2021

    Gay Responds to Myths and Suspicions About COVID-19 Vaccine Efficacy and Safety

    Cindy Gay, MD, MPH Cindy Gay, MD, MPH, associate professor of medicine, division of infectious diseases and medical director of the UNC HIV Cure Center, responded to myths and suspicions about the efficacy and safety of the COVID-19 vaccine in the Charlotte Post. The report acknowledges that while ‘some people have died from the vaccine,’ a close look at the details of these deat … Read more

  • victor-garcia-martinez

    Antiviral Proves Effective at Preventing, Treating COVID-19 In Lab

    Using a novel in vivo research model containing human lung tissue, UNC School of Medicine scientists led by Victor Garcia, PhD, and Angela Wahl, PhD, demonstrated that the broad spectrum, experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection in human tissue in the lab. Victor Garcia, MD The number of new COVID-19 cases continues … Read more